Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

19.91 +0.73 (+3.83%)

Streaming Delayed Price Updated: 12:39 PM EDT, Jul 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Pacira Pharmaceuticals Stock Scores A Healthy 79 Relative Strength Rating ↗

February 07, 2022

The Relative Strength (RS) Rating for Pacira Pharmaceuticals moved up into a new percentile Monday, as it got a small lift to 79.

Via Investor's Business Daily

Top Russell 2000 Stocks: Trading Opportunities For Next Week ↗

February 06, 2022

A security pattern traces the distinct movements of security prices that, once recognized, helps traders to make informed trading decisions. Let's look at some Russell 2000 stock opportunities by...

Via Talk Markets

64 Biggest Movers From Yesterday ↗

February 01, 2022

Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 31, 2022

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...

Via Benzinga

32 Stocks Moving In Monday's Mid-Day Session ↗

January 31, 2022

Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Friday. The company, last week, priced its IPO at $6 per share. Knightscope, Inc. (...

Via Benzinga

Maravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating ↗

January 03, 2022

One key metric to look for in a stock is 80-plus RS Rating. Maravai Lifesciences stock just hit that mark, with a jump from 71 to 81 Monday.

Via Investor's Business Daily

Amphastar Receives FDA Tentative Approval for Vasopressin

December 29, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / December 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has tentatively approved the Company's...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 22, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 22, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Ligand Pharmaceuticals Sees RS Rating Rise To 92 ↗

November 11, 2021

A Relative Strength Rating upgrade for Ligand Pharmaceuticals shows improving technical performance.

Via Investor's Business Daily

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

November 11, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 11, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Amphastar Pharmaceuticals, inc (AMPH) Q3 2021 Earnings Call Transcript ↗

November 08, 2021

AMPH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Amphastar Pharmaceuticals: Q3 Earnings Insights ↗

November 08, 2021

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021

November 08, 2021

Reports Net Revenues of $112.2 Million for the Three Months Ended September 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021

October 28, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / October 28, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2021 ended September 30,...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference

September 02, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Amphastar Pharmaceuticals, inc (AMPH) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

AMPH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021

August 09, 2021

Reports Net Revenues of $101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021

July 29, 2021

RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021,...

From Amphastar Pharmaceuticals, Inc.

Via AccessWire

Topics Regulatory Compliance

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

18 Key Biopharma Catalysts To Keep An Eye On In Q3 ↗

July 10, 2021

Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...

Via Benzinga

Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

AMPH earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: Amphastar Pharmaceuticals Q1 Earnings ↗

May 06, 2021

Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.82% over the...

Via Benzinga

A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data ↗

May 03, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped 185 points in the previous session. However, Wall Street recorded gains for...

Via Benzinga

Topics Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.